Chronic Otitis Media (COM)

Knowledge Check

Exam-style MCQs aligned with these notes. Available to Hyperexcision Scholar members.

Log in to access
Last updated: April 19, 2026Bookmark

Chronic otitis media is a long-standing infection of the middle ear (> 6 weeks), which is characterized by ear discharge and permanent perforation.

The incidence of chronic otitis media is high in developing countries. It affects all age groups and both sexes equally. It is also the single most important cause of hearing loss in the rural population.

Tubotympanic (safe) vs atticoantral (unsafe) chronic otitis media

Tubotympanic (safe)Atticoantral (unsafe)
LocationAnteroinferior middle earPosterosuperior middle ear
DescriptionCentral perforation with involvement of the eustachian tube and mesotympanumMarginal perforation with involvement of the attic, antrum, and mastoid
DischargeProfuse, mucoid, odourlessScanty, purulent
GranulationsUncommonCommon
PolypPaleRed and fleshy
CholesteatomaAbsentPresent
Risk of complicationLowHigh
AudiometryConductive hearing lossConductive or mixed hearing loss
  • Risk factors
    • Abnormal Eustachian tube
      • Cleft palate
      • Down syndrome
    • Cholesteatoma
    • Immune deficiency
    • Ciliary dysfunction
    • Radiation
  • Causative organisms
    • Mixed infection
    • Gram-negative bacilli
    • Staphylococcus
    • Anaerobes
  • Pathophysiology
    • Chronic inflammation of the middle ear space/mastoid due to chronic Eustachian Tube Dysfunction
    • Chronic Perforation or Presence of a cholesteatoma
  • Signs and symptoms
    • Ear discharge
      • Mucopurulent
      • Odorous
    • Hearing loss
      • Conductive hearing loss or mixed hearing loss
    • Bleeding from granulations, polyps, or trauma during cleaning
    • Low-grade otalgia
    • Pain (otalgia)
    • Vertigo
      • erosion of the lateral semicircular canal → labyrinthitis or meningitis
    • Persistent headache
      • Intracranial complication
    • Facial weakness
      • Erosion of the facial canal
    • Neck rigidity and photophobia
      • Meningitis
    • Diplopia
      • Petrositis – Gradenigo syndrome
    • Ataxia
      • Labyrynthitis
      • Cerebellar abscess
    • Swelling around the ear
  • Physical examination
    • Perforation of the tympanic membrane
    • Ear discharge
    • Retraction pockets (invaginations of the tympanic membrane)
  • Investigations
    • Examination under a microscope
      • Cholesteatoma
      • Bone destruction
      • Granuloma
      • Pockets of discharge
    • X-ray of mastoids or CT-scan of the temporal bone: indicated if there is an inability to visualize the tympanic membrane, facial weakness, suspected labyrinthine fistula, or intracranial complication
      • Extent of bone destruction
      • Degree of mastoid pneumatization
      • Cholesteatoma
      • Labyrinthine fistula
    • Culture and sensitivity of ear discharge
  • Treatment
    • Surgery to remove the disease and render the ear safe, e.g., mastoidectomy and adenoidectomy,
    • Reconstructive surgery to restore hearing, e.g., myringoplasty, tympanoplasty, and ossiculoplasty
  • Complications of Chronic Otitis Media
    • Intratemporal complications
      • Mastoiditis
      • Petrositis
      • Facial paralysis
      • Labyrinthitis
    • Intracranial complications
      • Extradural abscess
      • Subdural abscess
      • Meningitis
      • Brain abscess
      • Lateral sinus thrombophlebitis
      • Otitic hydrocephalus

Reference Intervals
Biochemistry
ACTHP: <80 ng/L
ALTP: 5–35 U/L
AlbuminP: 35–50 g/L
AldosteroneP: 100–500 pmol/L
Alk. phosphataseP: 30–130 U/L
α-AmylaseP: 0–180 IU/dL
α-FetoproteinS: <10 kU/L
Angiotensin IIP: 5–35 pmol/L
ADHP: 0.9–4.6 pmol/L
ASTP: 5–35 U/L
BicarbonateP: 24–30 mmol/L
BilirubinP: 3–17 μmol/L
BNPP: <50 ng/L
CRPP: <10 mg/L
CalcitoninP: <0.1 mcg/L
Calcium (ionized)P: 1.0–1.25 mmol/L
Calcium (total)P: 2.12–2.60 mmol/L
ChlorideP: 95–105 mmol/L
CholesterolP: <5.0 mmol/L
VLDLP: 0.128–0.645 mmol/L
LDLP: <2.0 mmol/L
HDLP: 0.9–1.93 mmol/L
Cortisol AMP: 450–700 nmol/L
Cortisol MidnightP: 80–280 nmol/L
CK ♂P: 25–195 U/L
CK ♀P: 25–170 U/L
CreatinineP: 70–100 μmol/L
FerritinP: 12–200 mcg/L
FolateS: 2.1 mcg/L
FSHP: 2–8 U/L ♂; >25 menopause
GGT ♂P: 11–51 U/L
GGT ♀P: 7–33 U/L
Glucose (fasting)P: 3.5–5.5 mmol/L
Growth hormoneP: <20 mu/L
HbA1C (DCCT)B: 4–6%
HbA1C (IFCC)B: 20–42 mmol/mol
Iron ♂S: 14–31 μmol/L
Iron ♀S: 11–30 μmol/L
Lactate (venous)P: 0.6–2.4 mmol/L
Lactate (arterial)P: 0.6–1.8 mmol/L
LDHP: 70–250 U/L
LHP: 3–16 U/L
MagnesiumP: 0.75–1.05 mmol/L
OsmolalityP: 278–305 mosmol/kg
PTHP: 0.8–8.5 pmol/L
PotassiumP: 3.5–5.3 mmol/L
Prolactin ♂P: <450 U/L
Prolactin ♀P: <600 U/L
PSAP: 0–4 mcg/mL
Protein (total)P: 60–80 g/L
Red cell folateB: 0.36–1.44 μmol/L
Renin (erect)P: 2.8–4.5 pmol/mL/h
Renin (recumbent)P: 1.1–2.7 pmol/mL/h
SodiumP: 135–145 mmol/L
TBGP: 7–17 mg/L
TSHP: 0.5–4.2 mU/L
T4P: 70–140 nmol/L
Free T4P: 9–22 pmol/L
TIBCS: 54–75 μmol/L
TriglyceridesP: 0.50–2.3 mmol/L
T3P: 1.2–3.0 nmol/L
Troponin TP: <0.1 mcg/L
Urate ♂P: 210–480 μmol/L
Urate ♀P: 150–390 μmol/L
UreaP: 2.5–6.7 mmol/L
Vitamin B12S: 0.13–0.68 nmol/L
Vitamin DS: 50 nmol/L
Arterial Blood Gases
pH7.35–7.45
PaCO₂4.7–6.0 kPa
PaO₂>10.6 kPa
Base excess±2 mmol/L
Urine
Cortisol (free)<280 nmol/24h
Hydroxyindole acetic acid16–73 μmol/24h
Hydroxymethylmandelic acid16–48 μmol/24h
Metanephrines0.03–0.69 μmol/mmol cr.
Osmolality350–1000 mosmol/kg
17-Oxogenic steroids ♂28–30 μmol/24h
17-Oxogenic steroids ♀21–66 μmol/24h
17-Oxosteroids ♂17–76 μmol/24h
17-Oxosteroids ♀14–59 μmol/24h
Phosphate (inorganic)15–50 mmol/24h
Potassium14–120 mmol/24h
Protein<150 mg/24h
Protein/creatinine ratio<3 mg/mmol
Sodium100–250 mmol/24h
Haematology
WCC4.0–11.0 ×10⁹/L
RBC ♂4.5–6.5 ×10¹²/L
RBC ♀3.9–5.6 ×10¹²/L
Hb ♂130–180 g/L
Hb ♀115–160 g/L
PCV ♂0.4–0.54 L/L
PCV ♀0.37–0.47 L/L
MCV76–96 fL
MCH27–32 pg
MCHC300–360 g/L
RDW11.6–14.6%
Neutrophils2.0–7.5 ×10⁹/L (40–75%)
Lymphocytes1.0–4.5 ×10⁹/L (20–45%)
Eosinophils0.04–0.44 ×10⁹/L (1–6%)
Basophils0–0.10 ×10⁹/L (0–1%)
Monocytes0.2–0.8 ×10⁹/L (2–10%)
Platelets150–400 ×10⁹/L
Reticulocytes0.8–2.0% / 25–100 ×10⁹/L
Prothrombin time10–14 s
APTT35–45 s
Paediatric
Pulse Rate (bpm)
Neonate140–160
Infant <1yr120–140
1–5 years110–130
5–12 years80–120
>12 years70–100
Respiratory Rate (tachypnoea)
0–2 months≥60/min
2–12 months≥50/min
1–5 years≥40/min
>5 years≥30/min
Blood Pressure (mmHg)
Term65/45
1 year75/50
4 years85/60
8 years95/65
10 years100/70
Weight Formulas
3–12 months(a + 9)/2 kg
1–6 years2a + 8 kg
>6 years(7a − 5)/2 kg
Haemoglobin (g/dL)
Term newborn13–20
1 month11–18
2 months10–15
1–2 years10–13
>2 years11–14
MUAC (6 months–5 years)
Obese>17.5 cm
Normal13.5–17.4 cm
At risk12.5–13.4 cm
Moderate malnutrition11.5–12.4 cm
Severe malnutrition<11.5 cm
Developmental Milestones
Social smile1.5 months
Head control4 months
Sits unsupported7 months
Crawls10 months
Stands unsupported10–12 months
Walks12–13 months
Talks18 months
CSF WBC (/mm³)
Term newborn0–25
>2 weeks0–5
Calculator

Leave a Reply

A moment of your time
Step 1 of 2

You are the reason this exists. Got 60 seconds? Help us improve Hyperexcision for every medical student who uses it.

The Hyperexcision Team